Main content

    Dystonia Clinical Trials

    Sutter Health participates in clinical trials related to Dystonia throughout their Northern California facilities. See the listing below for an overview of current trials, including contact information. For some trials, more detailed information can be found via the title link to ClinicalTrials.gov.

    Title: DYSPORT for Injection AbobotulinumtoxinA Neurotoxin Clinical and Health Economics Outcomes Registry in Cervical Dystonia (ANCHOR-CD) (Tercica, Inc.)Opens in a new window external site
    Decscription: The purpose of the protocol is to determine typical patient response to Dysport in the treatment of adult cervical dystonia (CD).
    Investigator: Matthew Arnold, MD
    Eligibility: Patients with Cervical Dystonia/Spasmodic Torticollis.
    Status: Active and open to enrollment
    Location: Alta Bates Summit Medical Center
    Contact: Jody Dosanjh 510-204-1610 Email: dosanjp@sutterhealth.org

    Title: A Phase IIIb, Multicentre, randomised, double-blind, placebo-controlled study evaluating the efficacy and safety of Dysport using 2 mL diution in adults with cervical dystonia.Opens in a new window external site
    Decscription: The purpose of the protocol is to evaluate the efficacy of Dysport using 2 mL dilution compared with placebo for the treatment of Cervical Dystonia.
    Investigator: Nicklesh Thakur, DO
    Eligibility: Patients 18 and over clinical diagnosed with cervical dystonia that have recently been treated with botox injections.
    Status: Active and open to enrollment
    Location: Sutter Medical Group | Sutter Institute for Medical Research
    Contact: Cammy Rieger, CRC, 916-453-5740, Email: riegerc@sutterhealth.org

    > See All Neurology Clinical Trials by Condition